There’s nothing more important than our health, and keeping up on the latest information regarding everything from the common cold to pandemics, and the latest in the treatment of illnesses and diseases that effect all of us is tantamount. Syndicated World News keeps you up to date with unbiased reliable information.
Drug used to control blood pressure may improve cancer patients’ response to immunotherapy
on Oct 31, 2020 at 1:36 am
The same biochemical triggers that spur a “fight or flight” response when we encounter threats may help tumor cells to thrive.
SARS-CoV-2 virus may target red marrow and prevent the formation of new erythrocytes
on Oct 31, 2020 at 1:32 am
Specialists from the Department of Fundamental Medicine of Far Eastern Federal University (FEFU) with Russian and Japanese colleagues have probed into mechanisms of COVID-19 inside-the-body distribution linked to erythrocytes damaging.
First-of-its-kind synthetic DNA vaccine designed against Powassan virus
on Oct 31, 2020 at 1:26 am
Scientists at The Wistar Institute have designed and tested the first-of-its-kind synthetic DNA vaccine against Powassan virus (POWV), targeting portions of the virus envelope protein.
Researchers seek to understand HIV-related attitudes of nursing faculty in six countries
on Oct 31, 2020 at 1:19 am
Since the earliest study about nursing faculty and students attitudes and beliefs about caring for people living with HIV/AIDS (PLHIV) in the early 1990’s, there have only been 17 additional studies. Knowledge in this area of study is still lacking to fill some gaps in understanding attitudes towards people living with the disease.
Potential treatment might make tumors more responsive to immunotherapy
on Oct 31, 2020 at 1:14 am
Cancer immunotherapies, which empower patients’ immune systems to eliminate tumors, are revolutionizing cancer treatment. Many patients respond well to these treatments, sometimes experiencing long-lasting remissions.
Glucose-lowering drugs have neutral effect on mortality, adverse outcomes in COVID-19 patients with type 2 diabetes
on Oct 31, 2020 at 1:10 am
In a preprint paper, “Impact of Glucose-Lowering Drugs on Mortality and Other Adverse Outcomes in Patients with Type 2 Diabetes Admitted for COVID-19,” researchers conclude a neutral effect on mortality and other adverse outcomes.
Mobile smartphone technology may be key to improving out-of-hospital cardiac arrest survival
on Oct 31, 2020 at 1:05 am
Mobile smartphone technology can accelerate first responder dispatch and may be instrumental to improving out of hospital cardiac arrest (OCHA) survival.
Researchers report a novel approach to generate T-cells faster
on Oct 31, 2020 at 12:57 am
Adoptively transferred T-cells can prolong survival and sometimes cure patients with advanced solid tumors. While promising, it can take months to generate the necessary T-cells to help these patients. Such slow speed makes this therapy impractical for most patients who need immediate treatment.
Princeton professor selected to receive new award recognizing faculty innovation
on Oct 31, 2020 at 12:45 am
Robert Prud’homme, professor of chemical and biological engineering at Princeton University, has been selected to receive the inaugural Dean for Research Award for Distinguished Innovation for the invention of flash nanoprecipitation, a method for creating nanoparticles that promises to improve the delivery of drugs throughout the body.
SARS-CoV-2 genetic mutations may have made COVID-19 more contagious
on Oct 31, 2020 at 12:42 am
A study involving more than 5,000 COVID-19 patients in Houston finds that the virus that causes the disease is accumulating genetic mutations, one of which may have made it more contagious.
New screening technique turns up genes tied to microcephaly, scientists say, and could be used for other developmental disorders
by Priyanka Runwal on Oct 30, 2020 at 5:26 pm
Scientists have developed a new human tissue screening technique that could be used to identify previously unknown genes tied to developmental disorders.
STAT+: Purdue law firm hires Justice Department lawyer who investigated the opioid maker
by Ed Silverman on Oct 30, 2020 at 4:17 pm
A prominent law firm that represents Purdue Pharma has hired a former Department of Justice lawyer who, as recently as seven months ago, was investigating the drug maker.
STAT+: Up and down the ladder: The latest comings and goings
by Ed Silverman on Oct 30, 2020 at 1:40 pm
From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry.
STAT+: Pharmalittle: Biden wins biotech support despite his policies; WHO sets Covid-19 compensation fund for low-income nations
by Ed Silverman on Oct 30, 2020 at 1:23 pm
From a policy perspective, Joe Biden should be biotech’s worst nightmare. But that isn’t stopping major biotech chief executives and investors from personally backing Biden’s campaign.
Opinion: The ever-expanding role of the chief medical officer
by Ashwini Zenooz on Oct 30, 2020 at 8:45 am
The pandemic has driven home the message that, in one sense or another, every company is now in the business of health.
Opinion: ‘Patient friction coefficient’ can gauge the burden of participating in a clinical trial
by David Cameron and Murray Aitken on Oct 30, 2020 at 8:40 am
Despite knowing that-less burdensome protocols would help optimize trial designs, accelerate recruitment, and reduce attrition, sponsors have struggled to bring the patient perspective into the trial design conversation.
Ashish Jha on Covid-19, pandemic fatigue, and when we’re getting back to normal
by Adam Feuerstein and Meg Tirrell and Damian Garde on Oct 30, 2020 at 8:35 am
>@ashishkjha is particularly helpful at cutting through the noise about the Covid-19 pandemic. So he joined STAT’s podcast, “The Readout LOUD,” to explain what’s happening now.
STAT+: Biden’s policies could spell trouble for biotech — but industry CEOs are backing him anyway
by Nicholas Florko and Kate Sheridan on Oct 30, 2020 at 8:30 am
Biden could be a potential disaster for the biotech industry. But its CEOs are supporting him more vocally than ever before.
Listen: Pfizer’s Covid-19 mystery, Ashish Jha on pandemic response, & STAT turns 5
by Damian Garde and Meg Tirrell and Adam Feuerstein on Oct 29, 2020 at 9:24 pm
When are we getting Covid-19 vaccine data? Will concerts ever be safe again? And what’s a “Bionomy”? Find out on the latest episode of “The Readout LOUD.” Listen now: #TheReadoutLOUD
STAT+: Trump administration finalizes rule forcing insurers to disclose negotiated prices, including for drugs
by Lev Facher on Oct 29, 2020 at 4:42 pm
The rule will force insurers to disclose the prices they negotiate with hospitals, doctors, and drug companies. But it won’t take effect until January 2022.